RSH 13.0% 2.6¢ respiri limited

Ann: SuperChem to Commence Sales of wheezo, page-122

  1. 141 Posts.
    lightbulb Created with Sketch. 85
    It's interesting to see how sentiment has changed despite no real negative news. In the last year with all the turbulence, I think a lot of people have adjusted expectations to think that share prices should automatically just double YoY, and result in quick wins.

    In reality, it's about patience and time in the market.

    A few considerations;
    - SP is up 60% YoY
    - FDA approval is expected Q1 21 (yes we all know it was originally Q4 20; this is still positive and it's worth noting this is out of the control of RSH management)
    - Deals continue to be signed with pharma partners and distributors, suggesting they see the value prop of the wheezo product
    - Plenty of cash in the bank for a small cap to allow for ongoing operations
    - A strong business plan and proven sales so far

    The truth is, no company just starts operating and selling out on day 1; this takes time and an ongoing pipeline to build sales organically.

    In short, have patience, trust in the fundamentals and stay positive; this is not going to go up 10x in a week but will pay off for those who wait.

    PS; if you have no interest in buying, that's cool; move on
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.6¢
Change
0.003(13.0%)
Mkt cap ! $29.81M
Open High Low Value Volume
2.2¢ 2.6¢ 2.1¢ $17.69K 789.3K

Buyers (Bids)

No. Vol. Price($)
2 99463 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 199999 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.